- ICH GCP
- Registr klinických studií v USA
- Klinická studie NCT02734212
Ending Self Stigma for PTSD (ESS-P)
Reducing Internalized Stigma Among Veterans With PTSD: A Pilot Trial
Přehled studie
Postavení
Podmínky
Intervence / Léčba
Detailní popis
Stigma and fear of stigma are widespread among Veterans with PTSD and both have pernicious effects on Veterans' well-being and participation in mental health treatment. Internalized stigma is a harmful consequence of societal stigma, and has been associated with decreased hope, self-esteem, personal motivation, morale, self-regard, and persistence regarding illness management among individuals with a range of mental illnesses. Internalized stigma also has negative impacts on the recovery and well-being of Veterans with PTSD specifically, but no evidence-based interventions are currently available to assist Veterans with PTSD in combatting the impact of internalized stigma. Therefore, the purpose of this proposal is to develop and pilot-test an intervention to provide Veterans with PTSD the skills to cope effectively with stigma and to mitigate the internalization of stigmatizing beliefs and stereotypes. To that end, the investigators will modify Ending Self Stigma (ESS), an intervention composed of evidence-based strategies for combating internalized stigma for mental illness developed by the investigators' team, to specifically serve the needs of Veterans with PTSD.
This proposed project is composed of two phases. In Phase I, the investigators will produce an intervention and accompanying manual for the PTSD version of ESS (ESS-P), based upon the strategies and structure of the existing ESS intervention. To this end, the investigators will interview Veterans with a PTSD diagnosis to learn more about their experience with societal and internalized stigma associated with PTSD, plus other considerations and issues in addressing internalized stigma with such Veterans. Information gleaned in these qualitative interviews will form the basis of the investigators' adaption of the ESS intervention to specifically address the needs of Veterans with PTSD. In Phase II, the investigators will pilot-test ESS-P with Veterans who have PTSD, to evaluate the feasibility and acceptability of the intervention. In addition, the investigators will preliminarily estimate the effects of ESS-P through comparison to a control group receiving only an informational brochure on internalized stigma associated with PTSD. These feasibility, implementation and pilot outcome data will be used to further refine the intervention, towards the goal of conducting a future larger scale study of ESS-P within the VA system.
Typ studie
Zápis (Aktuální)
Fáze
- Nelze použít
Kontakty a umístění
Studijní místa
-
-
Maryland
-
Baltimore, Maryland, Spojené státy, 21201
- Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD
-
-
Kritéria účasti
Kritéria způsobilosti
Věk způsobilý ke studiu
Přijímá zdravé dobrovolníky
Pohlaví způsobilá ke studiu
Popis
Inclusion Criteria:
- a diagnosis of PTSD
- age between 18 and 70
- participation in mental health services at the VAMHCS
- sufficient clinical stability to participate
Exclusion Criteria:
a diagnosis of serious mental illness
- schizophrenia/schizoaffective disorder
- bipolar disorder
- major depression with psychotic features
- participation in the Phase I qualitative study
Studijní plán
Jak je studie koncipována?
Detaily designu
- Primární účel: Léčba
- Přidělení: Randomizované
- Intervenční model: Paralelní přiřazení
- Maskování: Singl
Zbraně a zásahy
Skupina účastníků / Arm |
Intervence / Léčba |
---|---|
Experimentální: Ending Self-Stigma for PTSD
Ending Self Stigma for PTSD (ESS-P) is a 9-session small-group (6-8 persons) course designed to help individuals with PTSD develop skills to effectively cope with stigma and minimize the internalization of stigmatizing beliefs and stereotypes.
Sessions combine in-class lecture, discussion of relevance to group members' personal experiences, review and practice of strategies and skills, and group sharing, support, and problem-solving.
Each session is designed to focus on a specific strategy for addressing self-stigma.
|
Ending Self Stigma for PTSD (ESS-P) is a 9-session small-group (6-8 persons) course designed to help individuals with PTSD develop skills to effectively cope with stigma and minimize the internalization of stigmatizing beliefs and stereotypes.
Sessions combine in-class lecture, discussion of relevance to group members' personal experiences, review and practice of strategies and skills, and group sharing, support, and problem-solving.
Each session is designed to focus on a specific strategy for addressing self-stigma.
Ostatní jména:
|
Jiný: Enhanced Treatment as Usual
The comparison condition will consist of providing a pamphlet that discusses societal stigma and internalized stigma, and provides resources to help combat the effects of both.
Participants will be given the informational pamphlet and study staff will discuss its content with the participant.
|
The comparison condition will consist of providing a pamphlet that discusses societal stigma and internalized stigma, and provides resources to help combat the effects of both.
Participants will be given the informational pamphlet and study staff will discuss its content with the participant.
Ostatní jména:
|
Co je měření studie?
Primární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
---|---|---|
Internalized Stigma of Mental Illness Inventory (Internalized Stigma)
Časové okno: Basline and Post Treatment (~3 1/2 months)
|
The Internalized Stigma of Mental Illness Inventory was used to measure of internalized or self-stigma.
A total score is calculated by taking an average of the responses on the items (range=1 to 4).
Higher total scores indicate greater internalized stigma.
|
Basline and Post Treatment (~3 1/2 months)
|
Sekundární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
---|---|---|
General Self-Efficacy
Časové okno: Baseline and Post Treatment (~3 1/2 months)
|
The General Self-Efficacy subscale of Sherer's Self-Efficacy Scale was used to measure participant's general beliefs or expectations about their abilities.
A total score is calculated by summing the responses on the items (range= 17-85).
Higher score indicate greater general self-efficacy.
|
Baseline and Post Treatment (~3 1/2 months)
|
Social Self-Efficacy
Časové okno: Baseline and Post Treatment (~3 1/2 months)
|
The Social Self-Efficacy subscale of Sherer's Self-Efficacy Scale was used to measure participant's beliefs or expectations about their abilities with regards to social interactions/relationships.
A total score is calculated by summing the responses on the items (range= 5-30).
Higher score indicate greater social self-efficacy.
|
Baseline and Post Treatment (~3 1/2 months)
|
Spolupracovníci a vyšetřovatelé
Publikace a užitečné odkazy
Termíny studijních záznamů
Hlavní termíny studia
Začátek studia
Primární dokončení (Aktuální)
Dokončení studie (Aktuální)
Termíny zápisu do studia
První předloženo
První předloženo, které splnilo kritéria kontroly kvality
První zveřejněno (Odhad)
Aktualizace studijních záznamů
Poslední zveřejněná aktualizace (Aktuální)
Odeslaná poslední aktualizace, která splnila kritéria kontroly kvality
Naposledy ověřeno
Více informací
Termíny související s touto studií
Klíčová slova
Další relevantní podmínky MeSH
Další identifikační čísla studie
- D1432-P
- 1I21RX001432-01 (Grant/smlouva NIH USA)
Plán pro data jednotlivých účastníků (IPD)
Plánujete sdílet data jednotlivých účastníků (IPD)?
Tyto informace byly beze změn načteny přímo z webu clinicaltrials.gov. Máte-li jakékoli požadavky na změnu, odstranění nebo aktualizaci podrobností studie, kontaktujte prosím register@clinicaltrials.gov. Jakmile bude změna implementována na clinicaltrials.gov, bude automaticky aktualizována i na našem webu .
Klinické studie na Ending Self Stigma for PTSD
-
VA Office of Research and DevelopmentDokončenoSchizofrenie | Schizoafektivní porucha | Bipolární porucha | Velká deprese s psychotickými rysySpojené státy
-
Syracuse VA Medical CenterDokončeno
-
Vasyl' HoroshkoBogomolets National Medical UniversityDokončeno